Review
doi: 10.1128/AAC.01169-07. Epub 2007 Dec 10.Clinical and economic impact of common multidrug-resistant gram-negative bacilli
Affiliations
- PMID:18070961
- PMCID: PMC2258516
- DOI: 10.1128/AAC.01169-07
Item in Clipboard
Review
Clinical and economic impact of common multidrug-resistant gram-negative bacilli
Christian G Giske et al. Antimicrob Agents Chemother.2008 Mar.
Display options
Format
Display options
Format
No abstract available
References
- Ben-Ami, R., M. J. Schwaber, S. Navon-Venezia, D. Schwartz, M. Giladi, I. Chmelnitsky, A. Leavitt, and Y. Carmeli. 2006. Influx of extended-spectrum beta-lactamase-producingEnterobacteriaceae into the hospital. Clin. Infect. Dis. 42:925-934. - PubMed
- Bhavnani, S. M., P. G. Ambrose, W. A. Craig, M. N. Dudley, and R. N. Jones. 2006. Outcomes evaluation of patients with ESBL- and non-ESBL-producingEscherichia coli andKlebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance Program. Diagn. Microbiol. Infect. Dis. 54:231-236. - PubMed
- Biedenbach, D. J., G. J. Moet, and R. N. Jones. 2004. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn. Microbiol. Infect. Dis. 50:59-69. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
